Continuous Manufacturing to increase productivity
Win the race for higher productivity in pharmaceutical manufacturing
Less deviations in production, higher yields, shorter time to market and more profitable processes with lower costs for operation, equipment, and investment are the key factors for outpacing competition in the pharmaceutical industry. With our solutions for continuous manufacturing, you can pave the way to higher productivity.
Catch up on a continuous production systemContinuous manufacturing in the pharmaceutical industry offers substantial benefits – so substantial, in fact, that the US Food and Drug Administration (FDA) actively promotes the development and introduction of continuous process concepts in pharmaceutical manufacturing.
Shorter time-to-market with process analytical technology
Many pharmaceutical manufacturers are already converting their processes to adopt continuous production: Active ingredients are produced in compact, closed units, with a higher degree of automation and fewer manual interventions, and production steps that were performed sequentially in a classic batch process are integrated in a continuous process. Continuous production literally makes classic batch processes look outdated: the utilization of assets increases by 30% to 40%, and a product that previously took one or even two months in production is finished after two days.
Manufacturing right first time
The use of Process Analytical Technology (PAT) provides the technological basis for Continuous Manufacturing. PAT can be used to determine the clinical efficacy of an active ingredient by direct in-process gathering of quality data online. Our PAT solution SIMATIC SIPAT is widely considered one of the most advanced PAT software solutions in the industry and enables pharmaceutical manufacturers to increase their system capacity utilization by one-third and reduce production costs by 10-20 percent after just a short time.